Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Caris Life Sciences Inc (CAI)

Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute PR Newswire - Fri Dec 19, 7:30AM CST

IRVING, Texas , Dec. 19, 2025 /PRNewswire/ --  Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 27.94 (+0.29%)
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need PR Newswire - Tue Dec 16, 7:30AM CST

IRVING, Texas , Dec. 16, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 27.94 (+0.29%)
Financial Pressure Turns Healthcare AI From Pilots Into Profits BayStreet.ca - Fri Dec 12, 8:37AM CST

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – Healthcare providers shortened buying cycles from eight months to under seven as financial pressures...

VPT.VN : 0.140 (+21.74%)
CCLD : 3.21 (+0.31%)
ABSI : 3.38 (-0.88%)
LNAI : 1.0500 (+1.94%)
CAI : 27.94 (+0.29%)
VPTDF : 0.0901 (-1.42%)
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium PR Newswire - Thu Dec 4, 7:30AM CST

IRVING, Texas , Dec. 4, 2025 /PRNewswire/ --  Caris Life Sciences ®  (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 27.94 (+0.29%)
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute PR Newswire - Tue Dec 2, 7:30AM CST

IRVING, Texas , Dec. 2, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 27.94 (+0.29%)
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class PR Newswire - Fri Nov 21, 7:30AM CST

IRVING, Texas , Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 27.94 (+0.29%)
Caris Life Sciences to Attend Q4 2025 Investor Conferences PR Newswire - Mon Nov 17, 7:30AM CST

IRVING, Texas , Nov. 17, 2025 /PRNewswire/ --  Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 27.94 (+0.29%)
AI Wellness Market Surges as Personalized Health Platforms Capture Investment Flow BayStreet.ca - Wed Nov 12, 8:33AM CST

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – AI-powered wellness platforms are commercializing rapidly as major technology companies launch personalized health...

ZBH : 89.13 (-1.40%)
CAI : 27.94 (+0.29%)
CERT : 9.07 (+2.14%)
ACN : 272.25 (+0.85%)
ALEN-U.CN : 1.4500 (unch)
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance PR Newswire - Wed Nov 5, 3:05PM CST

Revenue growth of 113% driven by strong performance in molecular profiling services

CAI : 27.94 (+0.29%)
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response PR Newswire - Wed Oct 29, 7:30AM CDT

IRVING, Texas , Oct. 29, 2025 /PRNewswire/ -- Caris Life Sciences ®  (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced...

CAI : 27.94 (+0.29%)

Barchart Exclusives

As Google Launches Gemini 3 Flash, Should You Buy, Sell, or Hold GOOGL Stock? Barchart - Sun Dec 21, 3:35PM CST
Alphabet looks like a buy, with Gemini 3 Flash riding an AI data‑center boom, Google Cloud and Gemini winning large enterprise and infrastructure deals, and Wall Street assigning a "Strong Buy" rating. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot